Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study

INTRODUCTION: Therapeutic efficacy of disease-modifying therapies (DMTs) for multiple sclerosis (MS) is often hindered by poor persistence and adherence, impacted by patient-perceived efficacy concerns, adverse effects, inconvenience, and forgetfulness. This study measured persistence, adherence, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Araujo, Lita, Geertsen, Svend S., Amedume, Allen, Higuchi, Keiko, van Wingerden, Janneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588137/
https://www.ncbi.nlm.nih.gov/pubmed/36152222
http://dx.doi.org/10.1007/s40120-022-00404-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588137/
https://www.ncbi.nlm.nih.gov/pubmed/36152222
http://dx.doi.org/10.1007/s40120-022-00404-1

Ejemplares similares